Tag Archives: Drug Prices

Senators Demand Mylan Repay $50M to the Pentagon for EpiPen

A group of senators wants to know if Mylan Pharmaceuticals will refund $50 million for charging the Department of Defense “exorbitant rates” at retail pharmacies for the EpiPen emergency allergy device. Their demand followed a Reuters report last week that Pentagon spending … Continue reading

Posted in Compliance, Health Plans, Healthcare Spending, Medicaid, Medicare, NEWS, Pharmaceutical | Tagged | Comments Off on Senators Demand Mylan Repay $50M to the Pentagon for EpiPen

Feds Probing Express Scripts’ Relationships with Drugmakers, Specialty Pharmacies

Federal investigators are looking into Express Scripts’ dealings with pharma companies, charitable foundations and specialty pharmacies. The nation’s largest pharmacy benefit manager on Tuesday revealed it received a civil investigative demand in August from the U.S. Attorney’s Office for the Southern … Continue reading

Posted in Compliance, Health Plans, NEWS, Pharmaceutical | Tagged | Comments Off on Feds Probing Express Scripts’ Relationships with Drugmakers, Specialty Pharmacies

CMS’ Slavitt Signals Tough Stance on Drug Costs

Dive Brief: As the U.S. faces increasing drug costs, pharmaceutical companies and investors can either continue to fight reality or to face it, CMS acting Administrator Andy Slavitt told attendees at last week’s Biopharma Congress in Washington, DC. As things stand, … Continue reading

Posted in Health Plans, Healthcare Spending, NEWS, Pharmaceutical | Tagged | Comments Off on CMS’ Slavitt Signals Tough Stance on Drug Costs

Drug Price Hikes May be Hitting Hospitals Harder than Consumers

Skyrocketing drug prices have hit hospitals even harder than consumers, according to a recent study from America’s biggest hospital lobbies. Annual inpatient drug spending was up an average of 23.4% between 2013 and 2015, and 38.7% on a per admission … Continue reading

Posted in Affordable Care Act, Healthcare Spending, NEWS, Pharmaceutical | Tagged | Comments Off on Drug Price Hikes May be Hitting Hospitals Harder than Consumers

Government Health Plans Spent Over $1B On EpiPens

U.S. government health plans spent more than $1 billion on Mylan NV’s EpiPen emergency allergic reaction treatment between 2011 and 2015, according to figures released by the Centers for Medicare and Medicaid Services on Wednesday. Mylan is under scrutiny for … Continue reading

Posted in Compliance, Health Plans, Healthcare Spending, NEWS | Tagged | Comments Off on Government Health Plans Spent Over $1B On EpiPens